erlotinib hydrochloride has been researched along with Pachymeningitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer-Furlan, A; Hardesty, DA; Otto, B; Prevedello, DM; Priddy, B | 1 |
| Dhruva, N; Socinski, MA | 1 |
2 other study(ies) available for erlotinib hydrochloride and Pachymeningitis
| Article | Year |
|---|---|
Cerebrospinal Fluid Leak Rhinorrhea after Systemic Erlotinib Chemotherapy for Metastatic Lung Cancer: A Familiar Problem from an Unfamiliar Culprit.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Cerebrospinal Fluid Rhinorrhea; Cranial Fossa, Posterior; Endoscopy; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Meningitis; Nasal Cavity; Natural Orifice Endoscopic Surgery; Sella Turcica; Skull Base; Skull Base Neoplasms | 2017 |
Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Disease Progression; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Immunohistochemistry; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningitis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Quinazolines; Risk Assessment; Tomography, X-Ray Computed | 2009 |